Dieulafoy’s Lesion: Management and Long-Term Outcome

Romãozinho, José Manuel; Pontes, Jessica Montenegro; Lérias, Clotilde; Ferreira, Maria Angélica Pires; Freitas, D.

doi:10.1055/s-2004-814322

Cited by 62 publications

(52 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Su diagnóstico endoscópico puede ser difícil dado el pequeño tamaño de la lesión y el carácter intermitente de la hemorragia que provoca (8). Varias series recientes estiman que la LD puede ser la causa de hasta el 4-5% de las hemorragias digestivas altas (9,10).…”

unclassified

“…El tratamiento endoscópico de la LD logra hemostasia en la mayoría de los pacientes, con bajas tasas de recidiva y complicaciones (8)(9)(10)(11)(12)(13). Se han empleado diversas técni-cas endoscópicas: inyección de adrenalina (IA) y otras sustancias esclerosantes, coagulación con sondas de calor (CSC) o argón y técnicas de índole mecánica como la ligadura endoscópica con bandas (LEB) o la aplicación de hemoclips (8)(9)(10)(11)(12)(13)(14)(15).…”

unclassified

See 1 more Smart Citation

Aspectos clínicos y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy

Ibañez¹,

Castro

Fernández

et al. 2007

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy. Rev Esp Enferm Dig 2007; 99: 505-510. RESUMENObjetivo: conocer la incidencia, forma de presentación, localización y resultados del tratamiento endoscópico en la hemorragia digestiva causada por lesión de Dieulafoy.Material y métodos: se revisaron de forma retrospectiva todos los casos de hemorragia digestiva por lesión de Dieulafoy entre los años 2000 y 2006. Se recogieron los principales datos clí-nicos y endoscópicos, tipo de tratamiento empleado, eficacia del mismo, recidiva, complicaciones y mortalidad durante el ingreso.Resultados: se encontraron 41 pacientes, 26 varones y 15 mujeres, con edad media de 71,19 años. La lesión de Dieulafoy fue la causa del 1,55% de los casos de hemorragia digestiva aguda en el periodo estudiado. La incidencia de hemorragia digestiva por lesión de Dieulafoy fue de 2,2 casos por cada 100.000 habitantes y año. La mayoría de los pacientes presentaban hemorragia activa en el momento de la endoscopia (85,36%) y comorbilidad (92,68%). La localización más frecuente fue el estómago (60,97%), seguida del duodeno (29,26%). El tratamiento endoscópico logró la hemostasia inicial en el 100% de los casos. Tres pacientes (7,31%) presentaron recidiva hemorrágica, todos ellos habían sido tratados inicialmente con esclerosis con adrenalina y respondieron adecuadamente a un segundo tratamiento endoscó-pico. Ningún paciente precisó cirugía. La mortalidad durante el ingreso fue del 4,87%.Conclusiones: la lesión de Dieulafoy es una causa poco frecuente, pero potencialmente grave, de hemorragia digestiva y puede aparecer en cualquier punto del tracto gastrointestinal. El tratamiento endoscópico es eficaz y presenta pocas complicaciones. La esclerosis única con adrenalina se asocia a un mayor riesgo de recidiva hemorrágica.Palabras clave: Dieulafoy. Hemorragia digestiva. Tratamiento endoscópico. ABSTRACTObjective: the aim of the study was to assess the incidence, clinical presentation, location, and response to endoscopic therapy of gastrointestinal bleeding from Dieulafoy's lesion.Material and methods: all consecutive episodes of gastrointestinal bleeding due to Dieulafoy's lesion seen between 2000 and 2006 were retrospectively reviewed. All main clinical and endoscopic data were collected: type and efectiveness of endoscopic therapy, rebleeding, complications, and mortality during hospitalization.Results: we found 41 patients, 26 males and 15 females, median age of 71.19 years. Dieulafoy's lesion accounted for 1.55% of all gastrointestinal bleeding episodes during the study period. The incidence of Dieulafoy's lesion was 2.2 cases/100.000 inhabitants/year. Active bleeding at endoscopy was present in 85.36%, and comorbidity in 92.68%. The stomach was the most frequent location (60.97%), followed by duodenum (29.26%). Endoscopic therapy achieved initial hemostasis in all cases. Three patients (7.31%) initially treated with epinephrine injection showed rebleeding and properly responded to a second session of endoscopic t...

show abstract

unclassified

Aspectos clínicos y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy

Ibañez¹,

Castro

Fernández

et al. 2007

Rev. esp. enferm. dig.

View full text Add to dashboard Cite

show abstract

“…Hemostasis can be achieved with these methods up to 90% of bleeding lesions. Advances in endoscopic management has decreased the mortality rates from 80% to 8.6% [7]. However, the risk of recurrence in mono-therapy is documented 9-40% more than compared to patients undergoing combined methods [8].…”

Section: Discussionmentioning

confidence: 99%

An unusual cause of hemorrhagic shock: gastric Dieulafoy’s lesion

Erdoğan

Ferhatoğlu

Pehlevan

et al. 2019

The European Research Journal

View full text Add to dashboard Cite

Dieulafoy's lesion (DL) related massive gastrointestinal bleeding is a rare and mortal health condition. DL is a superficial vascular lesion of the gastric mucose that is mostly located in the proximal part of the stomach which is difficult to diagnose. Endoscopy is a safe and effective method for diagnosis and treatment. However, emergency surgery should be essential for diagnosis and treatment. Here we present a succesfull clinical and surgical management of a case with massive gastrointestinal bleeding related to gastric DL.

show abstract

“…7 At this time, there is no effective method for precise diagnosis because of inconclusive clinical symptoms and signs; therefore the treatment of gastrointestinal bleeding is a challenge for surgeons. [7][8][9][10] Frequently, it requires multiple methods to localize the bleeding site. 11,12 Endoscopic tools (capsule, double balloon, single balloon, and spiral enteroscopy) for deep small-bowel intubation have shown limited success for small-bowel lesion evaluation, in particular overt bleeding.…”

Section: Discussionmentioning

confidence: 99%

Small-Bowel Bleeding With Laparoscopic Resection Guided by Microcoil Placement

Dobradin

Henson²,

Mansilla

et al. 2014

CRSLS

View full text Add to dashboard Cite

Introduction: Small-bowel massive bleeding presents a complex diagnostic and therapeutic problem. Angiography can be used for localization and embolization of the overt gastrointestinal bleeding site. Because of the complex anastomotic network of blood vessels supplying the small intestine, precise identification is complicated and surgical resection of the bleeding site is difficult. We describe angiography-directed preoperative microcoil placement for a localization of the bleeding site using intraoperative fluoroscopy during laparoscopic small-bowel resection.

show abstract

Dieulafoy’s Lesion: Management and Long-Term Outcome

Abstract: Dieulafoy's lesion is a not uncommon cause of severe recurrent gastrointestinal bleeding. Endoscopic therapy is safe and effective in achieving permanent hemostasis. The long-term prognosis for Dieulafoy's lesion is excellent, even when patients are treated using endoscopic methods alone.

Cited by 62 publications

References 8 publications

Aspectos clínicos y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy

Aspectos clínicos y tratamiento endoscópico de la hemorragia digestiva por lesión de Dieulafoy

An unusual cause of hemorrhagic shock: gastric Dieulafoy’s lesion

Small-Bowel Bleeding With Laparoscopic Resection Guided by Microcoil Placement

Contact Info

Product

Resources

About